Pegintron Induction Therapy in HCV Non-Responders

PHASE3CompletedINTERVENTIONAL
Enrollment

110

Participants

Timeline

Start Date

July 31, 2002

Study Completion Date

November 30, 2005

Conditions
Hepatitis C
Interventions
DRUG

Peginterferon alfa-2b

DRUG

Ribavirin

Trial Locations (7)

1091HA

OLVG, Amsterdam

6815 AN

Rijnstate Ziekenhuis, Arnhem

6401 CX

Atrium Medisch Centrum, Heerlen

2300 RC

LUMC, Leiden

3000 CA

Erasmus MC, Rotterdam

4535 PA

Ziekenhuis Zeeuws Vlaanderen, Terneuzen

3584 CX

UMC, Utrecht

Sponsors
All Listed Sponsors
lead

Foundation for Liver Research

OTHER